Skip to main content
Have a personal or library account? Click to login
Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies Cover

Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies

Radiology and Oncology
Volume 42 (2008): Issue 2 (June 2008)
By:   
Open Access
|Jun 2008
References

References

  1. Vokes EE, Weichselbyum RR, Lippman SM, Hong WK. Head and neck cancer.1993; 328:184-94.
    Open DOISearch in Google Scholar
  2. Strojan P. Cathepsins and their endogenous inhibitors in clinical oncology.1996; 30: 120-33.
    Search in Google Scholar
  3. Stoka V, Turk B, Turk V. Lysosomal cysteine cathepsins: signaling pathways in apoptosis.2007; 388: 555-60.
    Open DOISearch in Google Scholar
  4. Kos J, Šmid L, Krašovec M, Svetic B, Lenarcic B, Vrhovec I, et al. Lysosomal proteases cathepsins D, B, H, L and their inhibitors stefins A and B in head and neck cancer.1995; 376: 401-5.
    Open DOISearch in Google Scholar
  5. Budihna M, Strojan P, Šmid L, Skrk J, Vrhovec I, Zupevc A, et al. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.1996; 377: 385-90.
    Open DOISearch in Google Scholar
  6. Strojan P, Budihna M, Šmid L, Vrhovec I, Skrk J. Prognostic significance of cysteine proteinases B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.2000; 6: 1052-62.
    Search in Google Scholar
  7. Strojan P, Oblak I, Svetic N, Šmid L, Kos J. Cysteine proteinase inhibitor cystatin C in squamous cell carcinoma of the head and neck: relation to prognosis.2004; 90: 1961-8.
    Open DOISearch in Google Scholar
  8. Lah TT, Kos J, Blejec A, Frkovic-Georgio S, Golouh R, Vrhovec I, et al. The expression of lysosomal proteinases and their inhibitors in breast cancer: possible relationship to prognosis of the disease.1997; 3: 89-99.
    Open DOISearch in Google Scholar
  9. Knoch H, Werle B, Ebert W, Spiess E. Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer.1994; 5: 77-85.
    Open DOISearch in Google Scholar
  10. Ebert E, Werle B, Jülke B, Kopitar-Jerala N, Kos J, Lah T, et al. Expression of cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue.1997; 421: 259-65.
    Open DOISearch in Google Scholar
  11. Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, et al. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.2002; 94: 116-28.
    Open DOISearch in Google Scholar
  12. Kuopio T, Kankaanranta A, Jalava P, Kronqvist P, Kotkansalo T, Weber E, et al. Cysteine proteinase inhibitor cystatin A in breast cancer.1998; 58: 432-6.
    Search in Google Scholar
  13. Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ, Brunner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis.2000; 6: 505-11.
    Search in Google Scholar
  14. Kos J, Lah T. Role of cystatins and stefins in cancer. In: Zerovnik E, Kopitar-Jerala N, Uversky V, editors.New York: Nova Science Publishers, Inc; 2006. p. 233-6.
    Search in Google Scholar
  15. Levičar N, Kos J, Blejec A, Golouh R, Vrhovec I, Frkovic-Grazio S, et al. Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients.2002; 26: 42-9.
    Open DOISearch in Google Scholar
  16. Lah TT, Kalman E, Najjar D, Gorodetsky E, Brennan P, Somers R, et al. Cells producing cathepsins D, B and L in human breast carcinoma and their association with prognosis.2000; 3: 149-60.
    Open DOISearch in Google Scholar
  17. Kręcicki T, Siewiński M. Serum cathepsin B-like activity as a potential marker of laryngeal carcinoma.1992; 249: 293-5.
    Open DOISearch in Google Scholar
  18. Bongers V, Konings CH, Grijpma AM, Steen I, Braakhuis BJM, Snow GB. Serum proteinase activities in head and neck squamous cell carcinoma patients.1995; 15: 2763-6.
    Search in Google Scholar
  19. Strojan P, Budihna M, Šmid L, Svetic B, Vrhovec I, Škrk J. Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck.2001; 48: 66-71.
    Search in Google Scholar
  20. Strojan P, Budihna M, Šmid L, Svetic B, Vrhovec I, Kos J, et al. Cathepsin H in squamous cell carcinoma of the head and neck.1999; 33: 143-51.
    Search in Google Scholar
  21. Siewiński M, Kręcicki T, Jarmułowicz J, Berdowska I. Cysteine proteinase inhibitors in serum of patients with head and neck tumors.1992; 2: 323-6.
    Search in Google Scholar
  22. Strojan P, Svetic B, Šmid L, Kos J. Serum cystatin C in patients with head and neck carcinoma.2004; 344: 155-61.
    Open DOISearch in Google Scholar
  23. Vigneswaran N, Zhao W, Dassanayake A, Muller S, Miller DM, Zacharias W. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer.2000; 31: 931-7.
    Open DOISearch in Google Scholar
  24. Macabeo-Ong M, Shiboski CH, Silverman S, Ginzinger DG, Dekker N, Wong DT, et al. Quantitative analysis of cathepsin L mRNA and protein expression during oral cancer progression.2003; 39: 638-47.
    Open DOISearch in Google Scholar
  25. Nikitakis NG, Rivera H, Lopes MA, Siavash H, Reynolds MA, Ord RA, et al. Immunohistochemical expression of angiogenesis-related markers in oral squamous cell carcinoma with multiple metastatic lymph nodes.2003; 119: 574-86.
    Open DOISearch in Google Scholar
  26. Kawasaki G, Kato Y, Mizuno A. Cathepsin expression in oral squamous cell carcinoma: Relationship with clinicopathologic factors.2002; 93: 446-54.
    Open DOISearch in Google Scholar
  27. Strojan P, Aničin A, Svetic B, Pohar M, Šmid L, Kos J. Stefin A and stefin B: markers for prognosis in inoperable squamous cell carcinoma of the head and neck.2007; 68: 1335-41.
    Open DOISearch in Google Scholar
  28. Bossard N, Descotes F, Bremond AG, Bobin Y, De Saint Hilaire P, Golfier F, et al. Keeping data continuous when analyzing the prognostic impact of the tumor marker: an example with cathepsin D in breast cancer.2003;82:47-59.
    Open DOISearch in Google Scholar
  29. Castiglioni T, Merino MJ, Elsner B, Lah TT, Sloane BF, Emmert-Buck MR. Immunohistochemical analysis of cathepsin D, B and L in human breast cancer.1994; 25: 857-62.
    Open DOISearch in Google Scholar
  30. Strojnik T, Židanik B, Kos J, Lah TT. Cathepsin B and L are markers for clinically invasive types of meningeomas.2001; 48: 598-605.
    Open DOISearch in Google Scholar
  31. Sinha AA, Quast BJ, Wilson MJ, Fernandes ET, Reddy PK, Ewing SL, et al. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.2002; 94: 3141-9.
    Open DOISearch in Google Scholar
  32. Kim R, Emi M, Tanabe K, Uchida Y, Arihiro K. The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment.2006; 32: 269-77.
    Open DOISearch in Google Scholar
  33. Johansson AC, Norberg-Spaak L, Roberg K. Role of lysosomal cathepsins in napthazarin- and Fasinduced apoptosis in oral squamous cell carcinoma cells.2006; 126: 70-81.
    Open DOISearch in Google Scholar
  34. Osmak M, Svetic B, Gabrijelčič-Geiger, Skrk J. Drug-resistant human laryngeal carcinoma cells have increased levels of cathepsin B.2001; 21: 481-4.
    Search in Google Scholar
  35. Zajc I, Hreljac I, Lah T. Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics.2006; 26: 3357-64.
    Search in Google Scholar
  36. Gewies A, Grimm S. Cathepsin-B and cathepsin-L expression levels do not correlate with sensitivity of tumor cells to TNF-alpha-mediated apoptosis.2003; 89: 1574-80.
    Open DOISearch in Google Scholar
  37. Nagaraj NS, Vigneswaran N, Zacharias W. Hypoxia inhibits TRAIL-induced tumor cell apoptosis: involvement of lysosomal cathepsins.2007; 12: 125-39.
    Open DOISearch in Google Scholar
  38. Wickramasinghe NS, Banerjee K, Nagaraj NS, Vigneswaran N, Zacharias W. Hypoxia alters cathepsin B/inhibitor profiles in oral carcinoma cell lines.2005; 25: 2841-9.
    Search in Google Scholar
  39. Horsman MR. Measurement of tumor oxygenation.1998; 42: 701-4.
    Open DOISearch in Google Scholar
  40. Strojnik T, Kos J, Židanik B, Golouh R, Lah T. Cathepsin B immunohistochemical staining in tumor and endothelial cells is a new prognostic factor for survival in patients with brain tumors.1999; 5: 559-67.
    Search in Google Scholar
  41. Campo E, Munoz J, Miquel R, Palacín A, Cardesa A, Sloane BF. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival.1994; 145: 301-9.
    Search in Google Scholar
  42. Elzagheid A, Kuopio T, Pyrhönen S, Collan Y. Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?2006; 1: 41.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-008-0006-4 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 69 - 81
Published on: Jun 11, 2008
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
head and neck cancer,
cathepsins,
stefins,
prognosis
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2008 Primož Strojan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 42 (2008): Issue 2 (June 2008)
Previous article
Next article